From IMI to IHI - We have a new name. Find out why, and what else has changed…

Why we're changing

Project factsheets

The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 4 projects/programmes

ARDAT

Accelerating research & development for advanced therapies

Ongoing IMI2 Rare/orphan diseases Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Drug delivery

EU-PEARL

EU patient-centric clinical trial platform

Ongoing IMI2 Diabetes & metabolic disorders Psychiatric diseases Infectious diseases Rare/orphan diseases Clinical trial design Clinical networks Patient involvement in R&D

Screen4Care

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies

Ongoing IMI2 Rare/orphan diseases Tools for pediatrics Artificial intelligence

STOPFOP

Saracatinib trial to prevent FOP

Ongoing IMI2 Rare/orphan diseases Conducting clinical trials